These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 21687954
21. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer. Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH. Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700 [Abstract] [Full Text] [Related]
22. Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer. Suzuki M, Shigematsu H, Nakajima T, Kubo R, Motohashi S, Sekine Y, Shibuya K, Iizasa T, Hiroshima K, Nakatani Y, Gazdar AF, Fujisawa T. Clin Cancer Res; 2007 Oct 15; 13(20):6087-92. PubMed ID: 17947472 [Abstract] [Full Text] [Related]
24. MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. Awad MM, Oxnard GR, Jackman DM, Savukoski DO, Hall D, Shivdasani P, Heng JC, Dahlberg SE, Jänne PA, Verma S, Christensen J, Hammerman PS, Sholl LM. J Clin Oncol; 2016 Mar 01; 34(7):721-30. PubMed ID: 26729443 [Abstract] [Full Text] [Related]
25. Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma. Cai YR, Zhang HQ, Zhang ZD, Mu J, Li ZH. Oncol Lett; 2011 Mar 01; 2(2):257-264. PubMed ID: 22866074 [Abstract] [Full Text] [Related]
27. [Detection of epidermal growth factor receptor and c-Met gene copies for prognostic evaluation of non-small cell lung cancer]. Ai T, Wang N, Song LP. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb 01; 31(2):285-8. PubMed ID: 21354913 [Abstract] [Full Text] [Related]
31. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba II. PLoS One; 2010 Feb 09; 5(2):e9112. PubMed ID: 20161759 [Abstract] [Full Text] [Related]
35. Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer. Qiu T, Li W, Zhang T, Xing P, Huang W, Wang B, Chu L, Guo L, Liu X, Li Y, Ying J, Li J. Clin Lung Cancer; 2018 Jul 09; 19(4):e391-e398. PubMed ID: 29338938 [Abstract] [Full Text] [Related]
40. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. Samulin Erdem J, Skaug V, Bakke P, Gulsvik A, Haugen A, Zienolddiny S. BMC Cancer; 2016 Jan 19; 16():28. PubMed ID: 26780934 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]